SCHEMBL11014001

SCHEMBL11014001

O=c1[nH]c2c(Cl)cc(Cl)cc2c(=O)n1CCCl

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ DDR1 Q08345 7/20 0.40
▸ ALDH1A1 P00352 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ GRIN2D O15399 1/20 0.37
▸ GRIN3B O60391 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ GRIN1 Q05586 1/20 0.37
▸ GRIN2A Q12879 1/20 0.37
▸ GRIN2B Q13224 1/20 0.37
▸ GRIN2C Q14957 1/20 0.37
▸ GRIN3A Q8TCU5 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ MEN1 O00255 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11009548 0.87 HPGD (0.40) DDR1ALDH1A1PKM
SCHEMBL11008112 0.76 CA12 (0.59) ALDH1A1MEN1POLBPKMKMT2A
SCHEMBL17485265 0.75 DDR1 (0.41) DDR1MEN1KMT2A
SCHEMBL17242648 0.73 KDM4E (0.60) DDR1ALDH1A1KDM4EGAAHSD17B10
SCHEMBL9631092 0.73 CA9 (0.59) KDM4EGAAMEN1KMT2A
SCHEMBL31393234 0.72 KDM4E (0.39) DDR1ALDH1A1KDM4EGRIN2DGRIN3B
SCHEMBL6618888 0.71 PARP1 (0.50) —
SCHEMBL10288925 0.68 TSHR (0.48) ALDH1A1HSD17B10MEN1KMT2A
SCHEMBL2732040 0.68 MPO (0.67) ALDH1A1KDM4EHSD17B10MEN1KMT2A
SCHEMBL4199990 0.67 ALDH1A1 (0.69) ALDH1A1KDM4EHSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4522945-A SEROTONINE ANTAGONISTS JANSSEN PHARMACEUTICA N.V. (BE) 1985-06-11 — — US disclosed
EP-0013612-B1 (PIPERIDINYLALKYL)QUINAZOLINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM JANSSEN PHARMACEUTICA N.V. (BE) 1983-11-09 — — EP disclosed
EP-0013612-A2 (Piperidinylalkyl)quinazoline derivatives, process for their preparation and pharmaceutical compositions containing them JANSSEN PHARMACEUTICA N.V. (BE) 1980-07-23 — — EP disclosed
Send feedback